- 询价
- Signalway Antibody
- 48067
- 2025年09月23日
- WB, ICC, IHC
- Mouse
- Human;Mouse
企业认证
相关产品推荐更多 >
![HDAC7 antibody[38516]](https://img1.dxycdn.com/p/s14/2025/0922/359/6146153295428599691.jpg!wh200)
![SMARCA1 Antibody[43663]](https://img1.dxycdn.com/p/s14/2025/0922/568/0046652811090600791.jpg!wh200)
![RSK4 Conjugated Antibody[C56550]](https://img1.dxycdn.com/p/s14/2025/0922/632/2321321568067599691.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Recombinant protein
- 形态：
liquid
- 保存条件：
Store at -20˚C
- 克隆性：
Monoclonal
- 适应物种：
Human;Mouse
- 保质期：
12 months
- 抗原来源：
Mouse
- 供应商：
南京赛戈巍生物科技有限公司
- 宿主：
Mouse
- 应用范围：
WB, ICC, IHC
- 靶点：
Uniprot：O14786
- 抗体英文名：
Neuropilin 1 Antibody
- 规格：
50ul/100ul
BCTL1 antibody
Brain specific transmembrane protein containing 2 CUB and 1 LDL receptor class A domains protein 1 antibody
Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1 antibody
BTCL1 antibody
C130005O10Rik antibody
FLJ41325 antibody
Neto1 antibody
NETO1_HUMAN antibody
Neuropilin and tolloid like 1 antibody
Neuropilin and tolloid-like protein 1 antibody
RGD1566269 antibody
计算分子量:103 kDa
配方:1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
应用详情:WB: 1:1,000-1:10,000
IHC: 1:50
ICC: 1:100-1:500
图片:
Western blot analysis on recombinant protein using anti-Neuropilin 1 Mouse mAb (Cat. # M0910-5).
,
Immunohistochemical analysis of paraffin- embedded mouse brain tissue using anti-Neuropilin 1 Mouse mAb (Cat. # M0910-5).
,
Immunofluorescent staining of Hela cells using anti-Neuropilin 1 Mouse mAb (Cat. # M0910-5).
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PriCells: Primary cells culture with supplement of vascular endothelial growth factor (VEGF)
) and neuropilin co-receptors on the cell surface, enhancing their ability to bind and activate the VEGF receptors (VEGFRs). Biology All members of the VEGF family stimulate cellular responses by binding to tyrosine kinase receptors (the VEGFRs) on the cell
images, indicating rapid and specific targeting of APP antibody to the lung (Fig. 2a, c). Region-of-interest and biodistribution analysis confirmed this lung-specific targeting with 65% of the injected dose per gram of tissue accumulating
技术资料暂无技术资料 索取技术资料
